Form 4: ACM Research Director Haiping Dun Sells 15,000 Shares

Sentiment:

SEC Form 4 Filing


Haiping Dun, a director at ACM Research, Inc., sold 15,000 shares of Class A Common Stock on May 22, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On May 22, 2024, Haiping Dun, a director of ACM Research, Inc., sold 15,000 shares of Class A Common Stock.
  • The sale was executed at a weighted average price of $22.88 per share, with individual transactions ranging from $22.58 to $23.31.
  • The transaction was conducted under a Rule 10b5-1 trading plan adopted on May 17, 2023.
  • Following the transaction, Haiping Dun still beneficially owns 874,329 shares of ACM Research, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the sale was conducted under a pre-arranged trading plan, suggesting it's not necessarily indicative of the director's view on the company's future prospects. It's a routine transaction.

Industry Context

Sales by company insiders are a common occurrence and are closely watched by investors for signals about the company's prospects. A pre-planned sale under Rule 10b5-1 suggests the sale was scheduled in advance to avoid concerns about insider trading.

Stakeholder Impact

  • The sale of shares by a director could create short-term selling pressure on the stock.
  • However, the pre-planned nature of the sale under Rule 10b5-1 mitigates concerns about insider information influencing the transaction.

Key Dates

DateDescription
05/17/2023Date the reporting person adopted the Rule 10b5-1 trading plan
05/22/2024Date of the transaction (stock sale)
05/24/2024Date of the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.